Butyrate stimulates the secretion of apolipoprotein B-100-containing lipoproteins from HepG2 cells by inhibiting the intracellular degradation

We have shown previously that sodium butyrate induces a 2-fold increase in the secretion of apo B-100 by HepG2 cells. The apo B-100 mRNA level was not changed in butyrate-treated cells, indicating regulation at the translational or co- or posttranslational level (Biochem. J. (1991) 278, 557-564). In this paper, the mechanism by which butyrate increases apo B-100 secretion was further investigated. Pulse-chase analysis showed that in control incubations only 18 ± 4% of the total amount of labelled apo B-100, present intracellularly after a 10 min pulse period, was secreted after a 90 min chase period, indicating that the major part of newly synthesized apo B-100 is degraded intracellularly. After addition of butyrate the secreted amount increased to 32 ± 6% of the total synthesized amount. Treatment of HepG2 cells with butyrate resulted in an enhanced intracellular concentration of triacylglycerols (+ 30%), with no or only a marginal effect on the cellular content of cholesterol and choresteryl esters. Secretion of triacylglycerols (+ 90%) and cholesteryl esters (+ 78%), but not of cholesterol, was increased to the same extent as apo B-100 secretion(+ 102%). The total mass of triacyrglycerols, i.e., the sum of triacylglycerols present intracellularly and secreted by HepG2 cells, was significantly increased upon incubation with butyrate (+ 32%), whereas the total mass of cholesteryl esters was not affected. Butyrate did not affect the buoyant density of apo B-100-containing lipoproteins secreted by HepG2 cells. These results suggest that an increased availability of triacylglycerols, formed after the addition of butyrate regulates the amount of apo B-100 degraded intracellurarly and consequently apo B-100 secretion.
Chemicals/CAS: Albumins; Apolipoprotein A-I; apolipoprotein B-100; Apolipoproteins B; Butyric Acid, 107-92-6; Butyric Acids